Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Trojano

Showing results (61-70 of 342) with videos related to

Pageof 35
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|April 16, 2026
Tysabri Observational Program (TOP): long-term safety and effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis over 15 yearsHelmut Butzkueven, Ludwig Kappos, Heinz Wiendl, et al.
Epilepsy & Behavior Reports|December 8, 2022
A case of repeated focal motor seizures as expression of an inflammatory cerebral process with suspected dysimmune etiologyGiovanni Falcicchio, Giovanni Boero, Teresa Francavilla, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Real world comparison of teriflunomide and dimethyl fumarate in naïve relapsing multiple sclerosis patients: Evidence from the Italian MS registerAurora Zanghì, Carlo Avolio, Maria Pia Amato, et al.
Journal of the Neurological Sciences|May 31, 2011
Anxiety and depression in multiple sclerosis patients around diagnosisAndrea Giordano, Franco Granella, Alessandra Lugaresi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2019
Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatmentJeffrey A Cohen, Maria Trojano, Ellen M Mowry, et al.
Biomedicines|April 16, 2020
PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein LevelsDomenico De Rasmo, Anna Ferretta, Silvia Russo, et al.
Journal of Neuroimmunology|March 7, 2003
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypesCarlo Avolio, Maddalena Ruggieri, Fabrizio Giuliani, et al.
The Journal of Headache and Pain|April 25, 2012
Serum levels of N-acetyl-aspartate in migraine and tension-type headacheMarina de Tommaso, Edmondo Ceci, Carmela Pica, et al.
Frontiers in Neurology|March 25, 2021
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric MethodLuca Bollo, Pietro Iaffaldano, Maddalena Ruggieri, et al.
Expert Opinion on Drug Safety|December 20, 2022
Current safety concerns about the use of antiseizure medications in pregnancyGiovanni Falcicchio, Emilio Russo, Antonio Fabiano, et al.
Pageof 35

Showing results (61-70 of 342) with videos related to

Sort By:
Pageof 35
Journal of Neurology, Neurosurgery, and Psychiatry|April 16, 2026
Tysabri Observational Program (TOP): long-term safety and effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis over 15 yearsHelmut Butzkueven, Ludwig Kappos, Heinz Wiendl, et al.
Epilepsy & Behavior Reports|December 8, 2022
A case of repeated focal motor seizures as expression of an inflammatory cerebral process with suspected dysimmune etiologyGiovanni Falcicchio, Giovanni Boero, Teresa Francavilla, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Real world comparison of teriflunomide and dimethyl fumarate in naïve relapsing multiple sclerosis patients: Evidence from the Italian MS registerAurora Zanghì, Carlo Avolio, Maria Pia Amato, et al.
Journal of the Neurological Sciences|May 31, 2011
Anxiety and depression in multiple sclerosis patients around diagnosisAndrea Giordano, Franco Granella, Alessandra Lugaresi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2019
Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatmentJeffrey A Cohen, Maria Trojano, Ellen M Mowry, et al.
Biomedicines|April 16, 2020
PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein LevelsDomenico De Rasmo, Anna Ferretta, Silvia Russo, et al.
Journal of Neuroimmunology|March 7, 2003
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypesCarlo Avolio, Maddalena Ruggieri, Fabrizio Giuliani, et al.
The Journal of Headache and Pain|April 25, 2012
Serum levels of N-acetyl-aspartate in migraine and tension-type headacheMarina de Tommaso, Edmondo Ceci, Carmela Pica, et al.
Frontiers in Neurology|March 25, 2021
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric MethodLuca Bollo, Pietro Iaffaldano, Maddalena Ruggieri, et al.
Expert Opinion on Drug Safety|December 20, 2022
Current safety concerns about the use of antiseizure medications in pregnancyGiovanni Falcicchio, Emilio Russo, Antonio Fabiano, et al.
Pageof 35